Skip to main content
. 2021 Jul 6;2021:9919729. doi: 10.1155/2021/9919729

Figure 4.

Figure 4

Inhibition of miR-214-3p reverses the decreased expression of GPX4 and eNOS upon ox-LDL treatment. (a) Representative Western blot and statistical analyses of VECs treated either with 100 mg/L ox-LDL or 100 mg/L ox-LDL+miR-214-3p inhibitor for GPX4; (b) representative Western blot and statistical analyses of eNOS in VECs treated either with 100 mg/L ox-LDL or 100 mg/L ox-LDL+miR-214-3p inhibitor. All values are expressed as the mean ± SD, n = 3. ∗∗P < 0.01, compared with the control group; #P < 0.05 and ##P < 0.01, compared with the ox-LDL treatment group.